Auskipra-Gn/A3 Liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań
Auskipra-Gn/A3 Liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań
Authorised
- Aujeszky's disease virus, strain Bartha K61, Live
Product identification
Medicine name:
Auskipra-Gn/A3 Liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań
Active substance:
- Aujeszky's disease virus, strain Bartha K61, Live
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Aujeszky's disease virus, strain Bartha K61, Live63095700.00/50% tissue culture infectious dose2.00millilitre(s)
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
Meat and offal5week
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 1377
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 4/02/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 4/02/2022